Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
暂无分享,去创建一个
[1] M. Sporn,et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. , 2011, Free radical biology & medicine.
[2] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[3] Jana Marie Schwarz,et al. MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.
[4] Olubunmi Abel,et al. ALSoD: A user‐friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics , 2012, Human mutation.
[5] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[6] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[7] H. Okazawa,et al. Increased oxidative stress is related to disease severity in the ALS motor cortex , 2015, Neurology.
[8] H. Li,et al. Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS , 2014, Neuroscience.
[9] Honghao Zhou,et al. Plant Polyphenol Curcumin Significantly Affects CYPIA2 and CYP2A6 Activity in Healthy, Male Chinese Volunteers , 2010, The Annals of pharmacotherapy.
[10] John Q. Trojanowski,et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.
[11] H. Juan,et al. Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers , 2007, European Journal of Clinical Pharmacology.
[12] Shang Li,et al. The role of telomere biology in cancer. , 2013, Annual review of pathology.
[13] Geoff Der,et al. Gender and telomere length: Systematic review and meta-analysis , 2014, Experimental Gerontology.
[14] Vincent J. Henry,et al. OMICtools: an informative directory for multi-omic data analysis , 2014, Database J. Biol. Databases Curation.
[15] Karsten M. Borgwardt,et al. The Evaluation of Tools Used to Predict the Impact of Missense Variants Is Hindered by Two Types of Circularity , 2015, Human mutation.
[16] D. Breljak,et al. Molecular basis of amyotrophic lateral sclerosis , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] John W Griffin,et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.
[18] R. D'Alessandro,et al. Telomerase expression in amyotrophic lateral sclerosis (ALS) patients , 2014, Journal of Human Genetics.
[19] M. Naidu,et al. Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus , 2008, Drugs in R&D.
[20] Colin Campbell,et al. An integrative approach to predicting the functional effects of non-coding and coding sequence variation , 2015, Bioinform..
[21] C. Shaw,et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase , 2010, Proceedings of the National Academy of Sciences.
[22] Albert C. Ludolph,et al. Guidelines for preclinical animal research in ALS/MND: A consensus meeting , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[23] Sufen Yang,et al. Curcumin Protects Dopaminergic Neuron Against LPS Induced Neurotoxicity in Primary Rat Neuron/Glia Culture , 2008, Neurochemical Research.
[24] Iuliana Ionita-Laza,et al. Sequence kernel association tests for the combined effect of rare and common variants. , 2013, American journal of human genetics.
[25] Yansu Guo,et al. Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity. , 2011, Biological & pharmaceutical bulletin.
[26] J. Hesselink. Reversible motor neuron disease. , 1992, Neurology.
[27] S. Inoue,et al. A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model , 2014, PloS one.
[28] M. Moss,et al. Protandim does not influence alveolar epithelial permeability or intrapulmonary oxidative stress in human subjects with alcohol use disorders. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[29] M. Majeed,et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.
[30] I. Gülçin,et al. Antioxidant and radical scavenging properties of curcumin. , 2008, Chemico-biological interactions.
[31] I. Katona,et al. Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. , 2012, Brain : a journal of neurology.
[32] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[33] A. Goris,et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans , 2012, Nature Medicine.
[34] Patrizia Sola,et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.
[35] Wael K Al-Delaimy,et al. Curcumin Content of Turmeric and Curry Powders , 2006, Nutrition and cancer.
[36] Warren W. Kretzschmar,et al. Molecular Signatures of Major Depression , 2015, Current Biology.
[37] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[38] A. Higginbottom,et al. S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis☆ , 2013, Free radical biology & medicine.
[39] A. Al-Chalabi,et al. An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[40] S. W. Pedersen,et al. Immune system alterations in amyotrophic lateral sclerosis , 2013, Acta neurologica Scandinavica.
[41] S. Yim,et al. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. , 2004, Journal of pharmacological sciences.
[42] D. Eastmond,et al. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. , 1995, Mutation research.
[43] S. C. Chafe,et al. Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis , 2012, Nature.
[44] P. Lansdorp,et al. Telomere length measurements using fluorescence in situ hybridization and flow cytometry. , 2004, Methods in cell biology.
[45] E. Blackburn,et al. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging , 2006, Nature Medicine.
[46] Gabor T. Marth,et al. Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.
[47] R. Reddel,et al. Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.
[48] J. Trojanowski,et al. A yeast functional screen predicts new candidate ALS disease genes , 2011, Proceedings of the National Academy of Sciences.
[49] K. K. Sakariah,et al. Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. , 2002, Journal of agricultural and food chemistry.
[50] J. Chang-Claude,et al. A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk , 2013, Human molecular genetics.
[51] Yongwook Choi,et al. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..
[52] R. Kaji,et al. Nuclear factor κ B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations. , 2012, Clinical neuropathology.
[53] J. Barrett,et al. Telomere length and common disease: study design and analytical challenges , 2015, Human Genetics.
[54] Hongyu Zhou,et al. The targets of curcumin. , 2011, Current drug targets.
[55] A. Ludolph,et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS , 2004, Neurology.
[56] M. Miyashita,et al. Effects of Curcumin Supplementation on Exercise-Induced Oxidative Stress in Humans , 2013, International Journal of Sports Medicine.
[57] T. Ma,et al. Applications and limitations of polymerase chain reaction amplification. , 1995, Chest.
[58] Justin C. Fay,et al. Identification of deleterious mutations within three human genomes. , 2009, Genome research.
[59] Ammar Al-Chalabi,et al. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.
[60] James D. Herbsleb,et al. Social coding in GitHub: transparency and collaboration in an open software repository , 2012, CSCW.
[61] T. Spector,et al. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. , 2006, International journal of epidemiology.
[62] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[63] K. Abel,et al. Curcumins Promote Monocytic Gene Expression Related to β-Amyloid and Superoxide Dismutase Clearance , 2011, Neurodegenerative Diseases.
[64] Andrew D. Johnson,et al. Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology , 2010, Proceedings of the National Academy of Sciences.
[65] P. Lansdorp,et al. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. , 2002, Cytometry.
[66] G. Grunwald,et al. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. , 2006, Free radical biology & medicine.
[67] T. Chiba,et al. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers , 2011, Cancer Chemotherapy and Pharmacology.
[68] Kunxi Zhang,et al. Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis , 2011, Brain Research.
[69] 新田 隆,et al. 心房細動手術(手術のtips and pitfalls) , 2007 .
[70] Xueying Wang,et al. Telomere shortening in human diseases , 2013, The FEBS journal.
[71] G. Atzmon,et al. Telomere Length and Aging , 2012 .
[72] Yansu Guo,et al. The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model , 2013, Laboratory Investigation.
[73] Johnny S. H. Kwan,et al. Predicting Mendelian Disease-Causing Non-Synonymous Single Nucleotide Variants in Exome Sequencing Studies , 2013, PLoS genetics.
[74] Y. Panahi,et al. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. , 2015, Clinical nutrition.
[75] Mauno Vihinen,et al. VariBench: A Benchmark Database for Variations , 2013, Human mutation.
[76] M. Nalls,et al. Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans , 2012, Human molecular genetics.
[77] Lorne Zinman,et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis , 2014, Nature Neuroscience.
[78] K. Chopra,et al. Protective effect of curcumin against chronic alcohol-induced cognitive deficits and neuroinflammation in the adult rat brain , 2013, Neuroscience.
[79] A. Sahebkar,et al. Curcuminoids Modulate Pro‐Oxidant–Antioxidant Balance but not the Immune Response to Heat Shock Protein 27 and Oxidized LDL in Obese Individuals , 2013, Phytotherapy research : PTR.
[80] Brittany N. Lasseigne,et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways , 2015, Science.
[81] Yung-Hyun Choi,et al. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia , 2007, Acta Pharmacologica Sinica.
[82] Michael Benatar,et al. Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.
[83] S. Petri,et al. Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis , 2008, Journal of neuropathology and experimental neurology.
[84] M. Diederich,et al. Effect of Curcumin on Nuclear Factor κB Signaling Pathways in Human Chronic Myelogenous K562 Leukemia Cells , 2009 .
[85] Kazunori Otsuka,et al. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients , 2013, Cancer Chemotherapy and Pharmacology.
[86] A. Al-Chalabi,et al. The epidemiology of ALS: a conspiracy of genes, environment and time , 2013, Nature Reviews Neurology.
[87] P. Lansdorp,et al. Telomere length measurements in leukocyte subsets by automated multicolor flow‐FISH , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[88] A. Shimatsu,et al. Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study. , 2015, Journal of nutritional science and vitaminology.
[89] E. Fisher,et al. SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[90] A. Akaike,et al. Potential protective effect of highly bioavailable curcumin on an oxidative stress model induced by microinjection of sodium nitroprusside in mice brain. , 2014, Food & function.
[91] V. Meininger,et al. APOE: A potential marker of disease progression in ALS , 2002, Neurology.
[92] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[93] P. O’Reilly,et al. Identification of seven loci affecting mean telomere length and their association with disease , 2013, Nature Genetics.
[94] P. Thongnopnua,et al. Effect of Different Curcuminoid Supplement Dosages on Total In Vivo Antioxidant Capacity and Cholesterol Levels of Healthy Human Subjects , 2011, Phytotherapy research : PTR.
[95] R. Reddel,et al. Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.
[96] Jing Zhao,et al. Neuroprotection by Curcumin in Ischemic Brain Injury Involves the Akt/Nrf2 Pathway , 2013, PloS one.
[97] Yansu Guo,et al. Neuroprotection by Monocarbonyl Dimethoxycurcumin C: Ameliorating the Toxicity of Mutant TDP-43 via HO-1 , 2014, Molecular Neurobiology.
[98] Carl D Langefeld,et al. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1 , 2013, Neurobiology of Aging.
[99] Ole Gredal,et al. Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria , 2004, Neuron.
[100] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[101] Ryan M. Layer,et al. SpeedSeq: Ultra-fast personal genome analysis and interpretation , 2014, Nature Methods.
[102] O. Hardiman,et al. Heritability of Amyotrophic Lateral Sclerosis: Insights From Disparate Numbers. , 2015, JAMA neurology.
[103] S. Petri,et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB–mediated pathogenic pathways , 2011, The Journal of experimental medicine.
[104] J. Belsh. ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers? , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[105] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[106] W. Ling,et al. Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. , 2012, World journal of diabetes.
[107] Yansu Guo,et al. Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin , 2012, Brain Research Bulletin.
[108] B. Gao,et al. Clinical Pharmacology: Advances and Applications Dovepress the Clinical Potential of Influencing Nrf2 Signaling in Degenerative and Immunological Disorders , 2022 .
[109] D. Brenner,et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.
[110] E. Blackburn,et al. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR , 2011, Nucleic acids research.
[111] G. Appendino,et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. , 2011, Journal of natural products.
[112] P. Shaw,et al. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. , 2010, Free radical biology & medicine.
[113] T. Gillingwater,et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.
[114] R. Layzer,et al. Subacute, reversible motor neuron disease , 1991, Neurology.
[115] P. Popovich,et al. Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis , 2014, Neuron.
[116] Geoffrey Burnstock,et al. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice , 2004, Nature Medicine.
[117] S. Srichairatanakool,et al. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. , 2010, Clinical biochemistry.
[118] B. Miller,et al. Phytochemical Activation of Nrf2 Protects Human Coronary Artery Endothelial Cells against an Oxidative Challenge , 2012, Oxidative medicine and cellular longevity.
[119] Heng Li. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.
[120] Dirk Merkel,et al. Docker: lightweight Linux containers for consistent development and deployment , 2014 .
[121] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[122] K. Maeda,et al. Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP , 2012, British journal of pharmacology.
[123] S. Ajroud‐Driss,et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.
[124] J. Julien,et al. Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis , 2014, Neurotherapeutics.
[125] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[126] S. Deep,et al. Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. , 2015, Biochimica et biophysica acta.
[127] C. Sander,et al. Determinants of protein function revealed by combinatorial entropy optimization , 2007, Genome Biology.
[128] Richard Durbin,et al. Estimating telomere length from whole genome sequence data , 2014, Nucleic acids research.
[129] Pamela A McCombe,et al. Effects of gender in amyotrophic lateral sclerosis. , 2010, Gender medicine.
[130] E. Génin,et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. , 2014, Brain : a journal of neurology.
[131] C. Azzalin,et al. Telomere elongation chooses TERRA ALTernatives , 2015, RNA biology.
[132] W. Xu,et al. Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies. , 2015, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[133] N. Pearce,et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study , 2014, The Lancet Neurology.